<?xml version="1.0" encoding="UTF-8"?>
<table xmlns="http://www.w3.org/1999/xhtml">
 <caption class="caption">
  <label class="label">Table 1</label>
  <p class="p" xmlns="">The effects of 
   <italic class="italic">N. sativa</italic> and its active component, thymoquinone (TQ) on neurological and mental disorders. 
  </p>
 </caption>
 <thead class="thead">
  <tr class="tr" xmlns="">
   <th align="left" rowspan="1" colspan="1" class="th">Neurological or mental Disorders</th>
   <th align="left" rowspan="1" colspan="1" class="th">Model used and intervention (s)</th>
   <th align="left" rowspan="1" colspan="1" class="th">Finding (mechanism)</th>
   <th align="center" rowspan="1" colspan="1" class="th">References</th>
  </tr>
 </thead>
 <tbody class="tbody">
  <tr class="tr" xmlns="">
   <td rowspan="2" align="left" colspan="1" class="td">Alzheimer's disease (AD)</td>
   <td align="left" rowspan="1" colspan="1" class="td">Lipopolysaccharide-induced AD in mice, received TQ (2.5 &amp; 5mg/kg) for 7 days.</td>
   <td align="left" rowspan="1" colspan="1" class="td">(i) ↓ TBARS &amp; 5-LOX levels 
    <break class="break"/>(ii) ↑ GSH extent and SOD action 
    <break class="break"/>(iii) Causes disaggregation of A 
    <italic class="italic">β</italic> peptide 
    <break class="break"/>(iv) prevents declining of neurons 
    <break class="break"/>(v) Slows degeneration of cognitive ability 
   </td>
   <td align="center" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B64" ref-type="bibr" class="xref">64</xref>, 
    <xref rid="B65" ref-type="bibr" class="xref">65</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" rowspan="1" colspan="1" class="td">A 
    <italic class="italic">β</italic>-induced neurotoxicity (analyzed by culturing hippocampus and cortical neurons). 
    <break class="break"/>TQ is administered along with A 
    <italic class="italic">β</italic>
    <sub class="sub">1−42</sub> for 72 hours 
   </td>
   <td align="left" rowspan="1" colspan="1" class="td">(i) Reducing A 
    <italic class="italic">β</italic>-induced neurotoxicity. (Improved cell viability) by: 
    <break class="break"/>(ii) Inhibiting mitochondrial membrane potential depolarization 
    <break class="break"/>(iii) Hindering reactive oxygen species generation 
   </td>
   <td align="center" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B66" ref-type="bibr" class="xref">66</xref>] 
    <break class="break"/>
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td colspan="4" rowspan="1" class="td">
    <hr class="hr"/>
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="left" colspan="1" class="td">Parkinson's disease (PD)</td>
   <td align="left" rowspan="1" colspan="1" class="td">1-methyl-4-phenylpyridinium (MPP 
    <sup class="sup">+</sup>) and rotenone-induced neurotoxicity in PD model, cultures were treated with TQ (0.01, 0.1, 1 and, 10 
    <italic class="italic">μ</italic>M) on day 8th for 4 days. 
   </td>
   <td align="left" rowspan="1" colspan="1" class="td">(i) Rescued dopaminergic neurons through: 
    <break class="break"/>(ii) Its antioxidant and anti-inflammatory effects 
   </td>
   <td align="center" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B67" ref-type="bibr" class="xref">67</xref>] 
    <break class="break"/>
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" rowspan="1" colspan="1" class="td">Experimental model of early PD induced by 6-hydroxydopamine neurotoxicity, pretreatment of daily TQ (5 &amp; 10 mg/kg) and one additional dose after surgery were used.</td>
   <td align="left" rowspan="1" colspan="1" class="td">(i) ↓ MDA level 
    <break class="break"/>(ii) Prevents loss of neurons in substantia nigra 
    <break class="break"/>(iii) Protects hippocampal &amp; human induced pluripotent stem cell against 
    <italic class="italic">α</italic>-synuclein induced synaptic toxicity 
   </td>
   <td align="center" rowspan="1" colspan="1" class="td"> [ 
    <xref rid="B68" ref-type="bibr" class="xref">68</xref>, 
    <xref rid="B69" ref-type="bibr" class="xref">69</xref>] 
    <break class="break"/>
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td colspan="4" rowspan="1" class="td">
    <hr class="hr"/>
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="3" align="left" colspan="1" class="td">Depression and anxiety</td>
   <td align="left" rowspan="1" colspan="1" class="td">(i) Open field and elevated plus maze models; forced swim test 
    <break class="break"/>(ii) Locomotor behavior in familiar and new environment in rats, 
    <italic class="italic">N. sativa </italic> oil (0.1 mL/day) aqueous seed extract (2 mL/day) orally for 4-6 weeks 
   </td>
   <td align="left" rowspan="1" colspan="1" class="td">(i) ↑ in open field activity &amp; struggling time 
    <break class="break"/>(ii) ↑ 5-HT 
    <break class="break"/>(iii) ↓ 5HIAA level in the brain 
    <break class="break"/>(iv) ↑ tryptophan level in plasma &amp; brain 
    <break class="break"/>(v) ↑ locomotors activity in novel environment 
    <break class="break"/>(vi) ↑ brain DA level 
   </td>
   <td align="center" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B59" ref-type="bibr" class="xref">59</xref>, 
    <xref rid="B70" ref-type="bibr" class="xref">70</xref>, 
    <xref rid="B71" ref-type="bibr" class="xref">71</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" rowspan="1" colspan="1" class="td">Stressed and unstressed mice, 10 and 20 mg/kg of TQ for 4 weeks</td>
   <td align="left" rowspan="1" colspan="1" class="td">Unstressed mice: at 10 &amp; 20 mg/Kg showed anti-anxiety 
    <break class="break"/>(i) without altering nitrite levels 
    <break class="break"/>(ii) ↑ GABA content (only 20mg/Kg). 
    <break class="break"/>Stressed mice: 20 mg/kg showed anxiolytic effects with 
    <break class="break"/>(i) ↓ plasma nitrite level 
    <break class="break"/>(ii) Reversal of reduced GABA 
   </td>
   <td align="center" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B72" ref-type="bibr" class="xref">72</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" rowspan="1" colspan="1" class="td">Randomized control trial on healthy human subjects, 
    <italic class="italic">N. sativa</italic> capsule (500 mg) daily for 4 weeks. 
   </td>
   <td align="left" rowspan="1" colspan="1" class="td">(i) Stabilize disturbed mood 
    <break class="break"/>(ii) ↓ anxiety 
    <break class="break"/>(iii) Modulate memory positively 
   </td>
   <td align="center" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B73" ref-type="bibr" class="xref">73</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td colspan="4" rowspan="1" class="td">
    <hr class="hr"/>
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="left" colspan="1" class="td">Epilepsy</td>
   <td align="left" rowspan="1" colspan="1" class="td">Pentylenetetrazole-induced seizure, 
    <italic class="italic">N. sativa</italic> oil; TQ 
   </td>
   <td align="left" rowspan="1" colspan="1" class="td">(i) Prevented seizure occurrence 
    <break class="break"/>(ii) ↓ Reactive oxygen species generation 
    <break class="break"/>(iii) Reduced seizure score 
    <break class="break"/>(iv) Showed additive effects with phenobarbitone 
   </td>
   <td align="center" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B74" ref-type="bibr" class="xref">74</xref>– 
    <xref rid="B76" ref-type="bibr" class="xref">76</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" rowspan="1" colspan="1" class="td">Double-blinded placebo randomized control trial (refractory epilepsy), TQ as adjunctive therapy for 4 weeks</td>
   <td align="left" rowspan="1" colspan="1" class="td">(i) Significant reduction of seizure frequency (those who received combination therapy)</td>
   <td align="center" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B77" ref-type="bibr" class="xref">77</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td colspan="4" rowspan="1" class="td">
    <hr class="hr"/>
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="left" colspan="1" class="td">Opioid dependence and Tolerance</td>
   <td align="left" rowspan="1" colspan="1" class="td">Morphine brought tolerance and dependency in mice, 4mL/kg of 
    <italic class="italic">N. sativa</italic> oil along with morphine (5mg/kg) 
   </td>
   <td align="left" rowspan="1" colspan="1" class="td">(i) Attenuated the development of tolerance 
    <break class="break"/>(ii) Inhibited nitric oxide overproduction 
    <break class="break"/>(iii) ↓ in brain MDA level 
   </td>
   <td align="center" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B78" ref-type="bibr" class="xref">78</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" rowspan="1" colspan="1" class="td">Randomized trial (on 35 known addicts of opiates), 500 mg 
    <italic class="italic">N. Sativa </italic>three times daily 
    <break class="break"/>
   </td>
   <td align="left" rowspan="1" colspan="1" class="td">(i) ↓ the withdrawal effects significantly 
    <break class="break"/>(ii) ↑ appetite (no significant weight gain) 
    <break class="break"/>(iii) No changes in physiological parameters (blood pressure, pulse and respiratory rate) 
   </td>
   <td align="center" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B79" ref-type="bibr" class="xref">79</xref>] 
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p charset="fn" class="fn">
   <p class="p" xmlns="">TBARs= Thiobarbituric acid reactive substances, GABA= gamma amino butyric acid, 5-HT= 5 hydroxytryptamine, MDA= malondialdehyde, DA= dopamine, 5HIAA= 5 hydroxyindoleacetic acid, GSH= glutathione peroxidase, SOD= superoxide dismutase, TQ= thymoquinone, A 
    <italic class="italic">β</italic>= beta amyloid peptides, ↑=increase, ↓=decrease. 
   </p>
  </p>
 </tfoot>
</table>
